# Quoin Pharmaceuticals Ltd.: Form 8-K, filed Aug 21, 2025

- Company: [Quoin Pharmaceuticals Ltd.](/companies/qnrx.md) (CIK 1671502)
- Form: 8-K
- Filed: 2025-08-21
- Accepted by EDGAR: Aug 21, 2025, 17:28 ET
- Period: 2025-08-15
- Accession: 0001104659-25-081480
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671502/000110465925081480/tm2524078d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671502/000110465925081480/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671502/000110465925081480/tm2524078d1_8k.htm

Filed Aug 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-081480. Last ingested by Listed: Nov 6, 2026, 18:24 ET. No prices; not investment advice.